Financial Ratios

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE4107.35-7.3 (-0.18 %)
PREV CLOSE ( ) 4114.65
OPEN PRICE ( ) 4196.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1685
TODAY'S LOW / HIGH ( )4083.45 4196.65
52 WK LOW / HIGH ( )3702.15 4940
NSE4113.35-1 (-0.02 %)
PREV CLOSE( ) 4114.35
OPEN PRICE ( ) 4148.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4113.35 (1)
VOLUME 57239
TODAY'S LOW / HIGH( ) 4075.00 4148.15
52 WK LOW / HIGH ( )3690 5000
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)136.38133.89108.77111.2993.78
   CEPS(Rs)159.44159.03132.68133.85109.39
   DPS(Rs)70.0030.0035.00330.0022.50
   Book NAV/Share(Rs)701.05626.10523.07742.18658.22
   Tax Rate(%)24.2820.7425.5920.7634.98
Margin Ratios
   Core EBITDA Margin(%)31.6030.7931.8226.6227.17
   EBIT Margin(%)32.7128.8630.5630.3731.79
   Pre Tax Margin(%)32.1828.4629.8729.8631.70
   PAT Margin (%)24.3722.5622.2323.6620.61
   Cash Profit Margin (%)28.4926.7927.1228.4624.04
Performance Ratios
   ROA(%)16.0917.2413.0012.2011.25
   ROE(%)20.5523.3017.1915.8915.07
   ROCE(%)27.5629.7823.6220.3823.22
   Asset Turnover(x)0.660.760.580.520.55
   Sales/Fixed Asset(x)1.902.071.751.811.90
   Working Capital/Sales(x)1.391.802.041.011.15
Efficiency Ratios
   Fixed Capital/Sales(x)0.530.480.570.550.53
   Receivable days20.9816.8922.8929.1528.62
   Inventory Days61.7759.4170.5769.3259.95
   Payable days109.35114.15176.59212.28250.57
Valuation Parameters
   PER(x)25.4032.5041.5736.1735.41
   PCE(x)21.7327.3634.0830.0730.36
   Price/Book(x)4.946.958.645.425.04
   Yield(%)2.020.690.778.200.68
   EV/Net Sales(x)5.777.008.747.536.38
   EV/Core EBITDA(x)15.3720.3324.6721.4018.12
   EV/EBIT(x)16.7123.3128.6124.7820.07
   EV/CE(x)3.584.746.023.683.37
   M Cap / Sales6.547.629.248.567.30
Growth Ratio
   Net Sales Growth(%)-7.1316.644.043.375.74
   Core EBITDA Growth(%)1.2713.244.863.2419.20
   EBIT Growth(%)6.8814.544.68-1.2320.59
   PAT Growth(%)1.8623.10-2.2618.6619.16
   EPS Growth(%)1.8623.10-2.2618.6619.16
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)3.792.772.423.453.03
   Quick Ratio(x)3.162.241.872.962.60
   Interest Cover(x)62.1373.2344.4559.36384.67
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.